PAR-24-113: International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2024.
National Institutes of Health offered grants to colleges and universities. Applications closed on March 9, 2026.
From the official notice on Grants.gov, last changed January 22, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeK01
- Clinical trialsIndependent clinical trial not allowed
- Funded byFIC
- Median yearly award$165,422
- Typical project length5 years
- K01, Mentored Research Scientist Career Development Award. Protected time with a mentor for a researcher building an independent career. Other open K01 notices.
Projects funded under PAR-24-113 were run by John E. Fogarty International Center for Advanced Study in the Health Sciences (FIC, 2 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-24-113 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-21-104 | January 4, 2021 | Closed March 8, 2023 | Closed |
Key dates
| Posted | January 22, 2024 |
|---|---|
| Deadline | March 9, 2026 |
| Archived by Grants.gov | April 14, 2026 |
Who can apply
This opportunity was open to colleges and universities.
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed
Is this a realistic fit?
- Most of the money in the 3 programs behind this notice (75% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty (applicants must be at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience in a low- or middle-income country (LMIC), as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including "low-income," "lower-middle-income," and "upper-middle-income" countries) leading to an independently-funded research career focused on global health. This Funding Opportunity Announcement (FOA) invites applications from postdoctoral research scientists and junior faculty from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of the LMIC under the mentorship of LMIC and U.S. mentors.
Funded under PAR-24-113 so far
NIH funded 2 projects under PAR-24-113 in fiscal 2025 to 2026, at 2 institutions. The median yearly award was $165,422.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Improving timing to open cranial surgery following traumatic brain injury in Lima, Peru using implementation science | Northwestern University | 2026 | $37,098 |
| Tuberculosis in Malawian children under five years old: exploring non-invasive diagnostic strategies and the impact of malnutrition on treatment pharmacokinetics | Henry Ford Health + Michigan State University Health Sciences | 2026 | $184,441 |
Who has won Research Related to Deafness and Communication Disorders grants before
From fiscal 2021 to 2025, Research Related to Deafness and Communication Disorders (93.173) awarded $2.1 billion across 2,231 grant awards, an average of $925,005 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Maryland | 73 | $82.4 million |
| Massachusetts Eye and Ear Infirmary | Massachusetts | 41 | $78.9 million |
| The University of Iowa | Iowa | 28 | $53.4 million |
| The Leland Stanford Junior University | California | 39 | $46.2 million |
| University of Wisconsin System | Wisconsin | 56 | $45.0 million |
Who has won Cancer Research Manpower grants before
From fiscal 2021 to 2025, Cancer Research Manpower (93.398) awarded $1.0 billion across 2,913 grant awards, an average of $359,612 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Sloan-Kettering Institute for Cancer Research | New York | 92 | $52.8 million |
| Dana-Farber Cancer Institute, Inc. | Massachusetts | 100 | $38.4 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | 65 | $35.5 million |
| The General Hospital Corporation | Massachusetts | 58 | $35.4 million |
| The Johns Hopkins University | Maryland | 69 | $33.7 million |
Who has won International Research and Research Training grants before
From fiscal 2021 to 2025, International Research and Research Training (93.989) awarded $329 million across 802 grant awards, an average of $409,951 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Yale Univ | Connecticut | 19 | $13.2 million |
| Makerere University College of Health Sciences | 28 | $10.2 million | |
| The Johns Hopkins University | Maryland | 20 | $9.5 million |
| University of North Carolina at Chapel Hill | North Carolina | 22 | $9.3 million |
| University of Maryland, Baltimore | Maryland | 14 | $8.7 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-24-113 still open?
No. It closed on March 9, 2026.
Who can apply for International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed?
National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed?
Closed March 9, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-24-113?
NIH RePORTER lists 2 projects funded under PAR-24-113 in fiscal 2025 to 2026, at 2 institutions. The most were at Northwestern University, Henry Ford Health + Michigan State University Health Sciences.
Who has won Research Related to Deafness and Communication Disorders grants before?
The largest recipients over five fiscal years were The Johns Hopkins University, Massachusetts Eye and Ear Infirmary, The University of Iowa. The program made 2,231 awards worth $2.1 billion in that time.
Similar open grants
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required)
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Clinical Trial Not Allowed)
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)